ArticleBiomolecules2025
First Identification, Recombinant Production, and Structural Characterization of a Putative Structural Protein from the Haseki Tick Virus Polyprotein.
Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Haseki tick virus (HSTV) is a recently discovered virus detected in human serum following tick bites, yet its protein repertoire remains uncharacterized. In this study, we applied an integrative approach based first on membrane topology prediction, followed by AI-based structural prediction and experimental validation to annotate the structural part of the HSTV polyprotein. For the first time, we recombinantly expressed one of the putative HSTV structural protein (SP1) and determined its overall architecture using small-angle X-ray scattering (SAXS). Structural comparisons of the AI-predicted HSTV SP1 models revealed only a vague resemblance to the pestiviral Erns and Npro. The strong agreement between experimental SAXS data and the AI-predicted HSTV SP1 model supported the conclusion that HSTV SP1 adopts a distinct spatial architecture in solution, one that is not captured by existing pestiviral structures but is reliably represented by modern AI-based prediction. Our findings indicate that HSTV SP1 adopts a fold not previously observed among characterized members of the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.